InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Wednesday, 10/15/2014 8:15:14 AM

Wednesday, October 15, 2014 8:15:14 AM

Post# of 346252
Alerts History
• 15-Oct-2014 14:08 - PEREGRINE PHARMACEUTICALS SAYS BAVITUXIMAB EXHIBITS SPECIFIC AND STRONG BINDING TO EBOLA VIRIONS AND EBOLA VIRUS (EBOV)-INFECTED CELLS IN VITRO
PEREGRINE PHARMACEUTICALS SAYS BAVITUXIMAB EXHIBITS SPECIFIC AND STRONG BINDING TO EBOLA VIRIONS AND EBOLA VIRUS (EBOV)-INFECTED CELLS IN VITRO PPHM.O - RTRS
15-Oct-2014 14:08
PEREGRINE PHARMACEUTICALS SAYS BAVITUXIMAB EXHIBITS SPECIFIC AND STRONG BINDING TO EBOLA VIRIONS AND EBOLA VIRUS (EBOV)-INFECTED CELLS IN VITRO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News